Cart
sales@molnova.com
Quercetin 3,5,7,3,4-pentamethyl ether
CAS No. 1247-97-8
Quercetin 3,5,7,3,4-pentamethyl ether( 3,5,7,3′,4′-Pentamethoxyflavone )
Catalog No. M23419 CAS No. 1247-97-8
Quercetin 3,5,7,3,4-pentamethyl ether is a natural product.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 68 | In Stock |
|
| 5MG | 111 | In Stock |
|
| 10MG | 178 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameQuercetin 3,5,7,3,4-pentamethyl ether
-
NoteResearch use only, not for human use.
-
Brief DescriptionQuercetin 3,5,7,3,4-pentamethyl ether is a natural product.
-
DescriptionQuercetin 3,5,7,3,4-pentamethyl ether is a natural product. It can induce adipogenesis on 3T3-L1 preadipocytes by regulating transcription factors at an early stage of differentiation.
-
In Vitro——
-
In Vivo——
-
Synonyms3,5,7,3′,4′-Pentamethoxyflavone
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1247-97-8
-
Formula Weight372.4
-
Molecular FormulaC20H20O7
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (67.14 mM)
-
SMILESCOc(cc1OC)cc(OC(c(cc2)cc(OC)c2OC)=C2OC)c1C2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Tidutamab
Tidutamab (XmAb-18087) is a humanized bispecific antibody targeting the growth inhibitory receptor 2 (SSTR2) and T-cell binding domain (CD3) with antitumor activity for the study of gastric neurosecretory tumors.
-
5-hydroxy-3,7-dimeth...
5-hydroxy-3,7-dimethoxy-2-phenylchromen-,a natural product obtained from the resinous exudate of Heliotropium huascoense.
-
[Lys3]–Bombesin
[Lys3]-Bombesin is a biological active peptide. (PET (Positron Emission Tomography) imaging of [Lys3]-bombesin is able to detect gastrin-releasing peptide receptor (GRPR) positive prostate cancer. An immunoconjugate of [Lys3]-bombesin and corresponding monoclonal antibody can specifically induce (CD64)-dependent monocyte and neutrophil-mediated lysis of small cell carcinoma.)
